HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential modulation of hippocampal chemical-induced injury response by ebselen, pentoxifylline, and TNFalpha-, IL-1alpha-, and IL-6-neutralizing antibodies.

Abstract
The proinflammatory cytokines tumor necrosis factor (TNFalpha), interleukin-1 (IL-1alpha), and interleukin-6 (IL-6) have been associated with various models of hippocampal damage. To examine their role in initiation of an acute hippocampal injury response, 21-day-old male CD-1 mice received an acute intraperitoneal (i.p.) injection of trimethyltin hydroxide (TMT; 2.0 mg/kg) to produce necrosis of dentate granule neurons, astrocyte, and microglia reactivity. Tremors and intermittent seizures were evident at 24 hr. Intercellular adhesion molecule-1 (ICAM-1), glial fibrillary acidic protein (GFAP), anti-apoptotic TNFalpha-inducible early response gene (A-20), macrophage inflammatory protein (MIP)-1alpha, TNFalpha, IL-1alpha, IL-6, and caspase 3 mRNA levels were significantly elevated. Pretreatment with the antioxidant, ebselen, decreased ICAM-1, A-20, and TNFbeta elevations. Pentoxifylline blocked elevations in A-20 and decreased elevations in GFAP mRNA levels. Neither prevented histopathology or behavioral effects. Intracisternal injection of TNFalpha-neutralizing antibody significantly inhibited both behavioral effects and histopathology. RNase protection assays showed that TMT-induced elevations in mRNA levels for ICAM-1, A-20, GFAP, MIP-1alpha, IL-1alpha, TNFalpha, TNFbeta, and caspase 3 were blocked by anti-TNFalpha. These data demonstrate a significant role for TNFalpha in an acute neuro-injury in the absence of contribution from infiltrating cells. The cerebellum shows limited if any damage after TMT; however, in combination with the i.c.v. injection, elevations were seen in GFAP and in EB-22, a murine acute-phase response gene homologous to the alpha (1)-antichymotrypsin gene. Elevations were similar for artificial cerebral spinal fluid and anti-IL-1alpha, and significantly increased with anti-TNFalpha, anti-IL-6, or the combination of antibodies. Responses seen in the cerebellum suggest synergistic interactions between the baseline state of the cell and manipulations in the cytokine environment. Data suggests a role for TNFalpha in the pathogenesis of hippocampal injury induced by TMT.
AuthorsG Jean Harry, Alessandra Bruccoleri, Christian Lefebvre d'Hellencourt
JournalJournal of neuroscience research (J Neurosci Res) Vol. 73 Issue 4 Pg. 526-36 (Aug 15 2003) ISSN: 0360-4012 [Print] United States
PMID12898537 (Publication Type: Comparative Study, Journal Article)
CopyrightPublished 2003 Wiley-Liss, Inc.
Chemical References
  • Antibodies
  • Azoles
  • Cytokines
  • Drug Combinations
  • Glial Fibrillary Acidic Protein
  • Interleukin-1
  • Interleukin-6
  • Isoindoles
  • Lectins
  • Neuroprotective Agents
  • Neurotoxins
  • Organoselenium Compounds
  • RNA, Messenger
  • Trimethyltin Compounds
  • Tumor Necrosis Factor-alpha
  • trimethyltin hydroxide
  • ebselen
  • Pentoxifylline
Topics
  • Animals
  • Antibodies (immunology)
  • Azoles (therapeutic use)
  • Brain Injuries (chemically induced, immunology, prevention & control)
  • Cerebellum (drug effects, metabolism)
  • Cytokines (genetics, immunology, metabolism)
  • Disease Models, Animal
  • Drug Combinations
  • Gene Expression Regulation (drug effects)
  • Glial Fibrillary Acidic Protein (metabolism)
  • Hippocampus (drug effects, metabolism, pathology)
  • Interleukin-1 (immunology, metabolism)
  • Interleukin-6 (immunology, metabolism)
  • Isoindoles
  • Lectins (metabolism)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Microglia (drug effects, metabolism)
  • Neuroprotective Agents (therapeutic use)
  • Neurotoxins (toxicity)
  • Nuclease Protection Assays (methods)
  • Organoselenium Compounds (therapeutic use)
  • Pentoxifylline (therapeutic use)
  • RNA, Messenger (biosynthesis)
  • Trimethyltin Compounds (toxicity)
  • Tumor Necrosis Factor-alpha (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: